Cite

Targeting MET Amplification as a New Oncogenic Driver.

MLA

Hisato Kawakami, et al. “Targeting MET Amplification as a New Oncogenic Driver.” Cancers, vol. 6, no. 3, Sept. 2014, pp. 1540–52. EBSCOhost, https://doi.org/10.3390/cancers6031540.



APA

Hisato Kawakami, Isamu Okamoto, Wataru Okamoto, Junko Tanizaki, Kazuhiko Nakagawa, & Kazuto Nishio. (2014). Targeting MET Amplification as a New Oncogenic Driver. Cancers, 6(3), 1540–1552. https://doi.org/10.3390/cancers6031540



Chicago

Hisato Kawakami, Isamu Okamoto, Wataru Okamoto, Junko Tanizaki, Kazuhiko Nakagawa, and Kazuto Nishio. 2014. “Targeting MET Amplification as a New Oncogenic Driver.” Cancers 6 (3): 1540–52. doi:10.3390/cancers6031540.